4 months of undiagnosed liver condition in Almaty — fully diagnosed in Beijing in 6 days

I am forty-six, in the building-materials trade in Almaty, never had major health issues. Last autumn I started feeling unusually fatigued with occasional dull pain in my right upper abdomen. A checkup showed sky-high liver enzymes — ALT over 300, AST over 200. An ultrasound revealed a 2-centimeter mass in the right hepatic lobe, which the radiologist described as "nature unclear, recommend contrast-enhanced MRI and needle biopsy." When could I get the contrast MRI? Two-month wait. The biopsy? Four months. Kazakhstan does not lack good doctors, but medical resources are hyper-concentrated — all of Almaty shares a handful of imaging machines.

I inquired in Moscow and Istanbul. Turkish private hospitals would charge USD 8,000 and up for a full liver workup with biopsy, plus language barriers. A friend who had done business in Beijing said, "Why not go to China? The big Beijing hospitals have far better equipment than Turkey, and Almaty to Beijing is only a four-hour flight — closer than Moscow." He introduced me to MyMedVia. My native language is Russian, my English is basic, my Chinese is zero — but they arranged a Russian-speaking interpreter. Same day: consultation form received, reply within hours.

Flew to Beijing. Saw the chief of gastroenterology that afternoon — a veteran professor with forty years of liver-disease experience. He reviewed my Almaty ultrasound and said, "Morphologically this looks like hemangioma, but malignancy must be ruled out. We will check everything as fast as possible." Day two — full workup: contrast-enhanced MRI, FibroScan, viral markers, tumor markers, autoimmune antibodies. Day three — MRI results confirming hemangioma, under 2 cm, benign, no intervention needed. But they also found something else: chronic hepatitis B, with F2 fibrosis on FibroScan. Had I not come, that would have silently progressed.

Eight months on antiviral therapy now. Liver enzymes are completely normal, FibroScan shows fibrosis regressed from F2 to F1. The hemangioma was rechecked — unchanged, continue monitoring. Looking back at the two months I spent waiting for tests in Almaty: the psychological toll aside, another year or two of undiagnosed hepatitis B could have pushed fibrosis to F3 or even cirrhosis. The whole Beijing trip cost under USD 2,500 including flights and accommodation — two-thirds less than going to Turkey. But honestly, you cannot put a price on catching a silent liver disease before it becomes irreversible.